0000950170-24-073349.txt : 20240614 0000950170-24-073349.hdr.sgml : 20240614 20240614082124 ACCESSION NUMBER: 0000950170-24-073349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Upton Richard A CENTRAL INDEX KEY: 0001375726 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40228 FILM NUMBER: 241043211 MAIL ADDRESS: STREET 1: 12 MIDDLE STREET CITY: AMHERST STATE: NH ZIP: 03031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Carmell Corp CENTRAL INDEX KEY: 0001842939 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 861645738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2403 SIDNEY STREET, SUITE 300 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: 412-894-8248 MAIL ADDRESS: STREET 1: 2403 SIDNEY STREET, SUITE 300 CITY: PITTSBURGH STATE: PA ZIP: 15203 FORMER COMPANY: FORMER CONFORMED NAME: Carmell Therapeutics Corp DATE OF NAME CHANGE: 20230727 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III DATE OF NAME CHANGE: 20210127 4 1 ownership.xml 4 X0508 4 2024-06-12 0001842939 Carmell Corp CTCX 0001375726 Upton Richard A C/O CARMELL CORPORATION 2403 SIDNEY STREET, SUITE 300 PITTSBURGH PA 15203 true false false false false Common Stock 2024-06-12 4 P false 2000 2.2046 A 6400 D Common Stock 2021-09-23 4 J false 0 0 A 54445 D The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.1835 to $2.2257, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 The shares beneficially owned by the Reporting Person include 54,455 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of June 12, 2024. /s/ Richard Upton 2024-06-14